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INTRODUCTION 
 
As know, the recent expansion of implanted devices for cardiac 
pacing and defibrillation and the rise of mean age is consequently 
associated to increase in device-related complications number. However , 
the management of infection or malfunction leads has been modified by the 
introduction in the clinical pratice of transvenous lead removal, a technique 
able to treat all the leads-related complications1,  
The indications, facilities and training to removal chronically 
implanted leads have been codified from the NASPE Policy Consensus 
Conference in 20002.  
The transvenous lead extraction is a complex procedure, often 
associated to rare but severe complications; it needed by availability of new 
technique and materials in continous evolution and by the possibility of 
different approaches, beside resulting hardly dependent from the staff 
experience3.  
Actually, two different techniques in transvenous leads removal are 
used: the extraction with mechanical dilators or with powered sheaths. The 
first one, was introduced by Byrd in the late ’80s; it is performed with 
polypropylene sheaths and other dedicate tools (locking stylets, Lasso 
loop-retriver, Catcher, Transfemoral workstation etc..), that allow to apply 
longitudinal forces of pression, traction and countertraction, useful to 
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adherences dissection above the lead all over the venous tree and inside 
the heart4,5. The literature report a high success rate of this technique, with 
a low major-complications’ incidence6. On the other hand, the powered 
techniques, developed in the ‘90s, use a source of energy (Laser or 
Radiofrequency) delivered at the edge of a special sheath; the advantage 
is to make dissection of binding sites easier and faster. However, the 
success rate from literature is similar to the mechanical one, but the 
powered removal procedures are more expansive and more frequently 
associated to serious complications as tamponade, hemothorax, pulmonary 
embolism, led migration and death7,8.  
Independently from the choice of one technique, there are two 
possible conventional approachs: the superior one (through the original 
venuos entry site, when the proximal end of the lead is exposed) or the 
inferior one (through the femoral vein, useful for example in case of total 
intravascular leads)9. 
Percutaneous lead removal has been still associated with a small but 
significant procedural failure, morbidity and mortality. Many factors can 
influenced effectiveness, complexity, duration and outcome. We can 
describe clinical factors (related to the patient and lead story) and technical 
factors (structural or acquired characteristics of the leads)10. 
As known from the literature, the success rate of removal is strongly 
affected by the presence of fibrotic and calcified scar tissue develops 
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above the lead, by the impossibility of advancing a stylet into the lead 
usually caused from damage (previous or new damage during the dilation), 
or by the presence of free-floating intravascular leads11. 
According to these observations, in order to resolve these specific 
troubles, we have been developing a modified percutaneous mechanical 
dilatation technique: the Internal Transjugular Approach (ITA). Really, this 
method is not a new technique, just a modification of the standard one, 
using as different approach the right internal jugular vein. In our personal 
experience12, it presents some advantages, because it results able to 
overcome the most important procedural difficulties (strongly adherences, 
damage or intravascular leads), improving success rate and reducing 
complications of the transvenous lead extraction13. 
 
 
 
AIM OF THE STUDY. 
 
The aim of this study is to evaluate if the Internal Transjugular 
Approach can enhance the success rate of the standar mechanical 
technique of transvenous lead extraction, without an increase of 
complications incidences (evaluation of effectiveness and safety), useful in 
case of particulary difficult procedures. 
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MATERIALS and METHODS 
 
POPULATION 
Between October 2005 and July 2007, we evaluated consecutive 
patients admitted at our Electrophysiology Laboratory for submission to 
transvenous lead extraction procedures. The study-inclusion criterions 
were the indications to the procedures, according to the currently used 
NASPE Guidelines. 
The indications to transvenous leads extraction are divided in Class I 
(general agreement that leads should be removed) and Class II (leads are 
often removed but there is some divergence of opinion with respect to the 
benefit versus risk of removal) and moreover they are classified as 
following: 
I-a) Sepsis (including endocarditis) secondary to an infection of the 
pacing system; 
I-b) Retained lead, lead fragment or extraction hardware; 
I-c) Occlusion of all useable veins, with the need to implant a new 
lead; 
I-d) Lead interfering with the operation of another implanted device; 
II-a) Localized pocket infection, erosion or chronic draining sinus that 
does not involve the transvenous portion of the lead; 
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II-b) Occult infection (no source can be found, pacing system is 
suspected); 
II-c) Chronic pain at the pocket or lead insertion site not manageable 
without lead removal; 
II-d) A lead that, due to its design or its failure, may pose a threat to 
the patient; 
II-e) Interference with the treatment of a malignancy; 
II-f) Traumatic injury for which the lead may interfere with 
reconstruction; 
II-g) Non-functional leads in young patient. 
The clinical and pacing notes of all patients were reported into a 
structured database and then evaluated. In particular, we recorded: 
a) patient clinical data (age, sex, case history and comorbidity); 
b) lead data (leads total number; trade-name, implant period, pacing or 
defibrillating type, site of pacing, intravascular or exposed location, 
access vein, eventually previous procedures or damages); 
c) indication to removal (according to the Guidelines). 
We randomized the patients, through a simple randomization order, 
into two Groups: 
A) Standard Group, 
B) Internal Transjugular Approach (ITA) Group. 
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The Group-A patients and theirs relatives leads were submitted to a 
standard removal procedure, according to the global experience, through 
the mechanical dilation technique describe in literature. 
The Group-B patients were approached with the same standard 
procedure as first step, only in case of failure we performed our personal 
technique, using the Internal Transjugular Approach (ITA), as second step. 
 
PROCEDURE 
The procedures were performed in the Cardiac Electrophysiology 
Laboratory, in Cardiac and Thoracic Department, at the Cisanello Hospital 
(Pisa). We obtained informed consent, also regarding the possibility to use 
the availables different approaches, in order to obtain the clinical success 
of the procedure.  
Before the procedure, all the patients were submitted to 2P X-Ray 
and TransthoracicEchography, than during the procedure (with local 
anaesthesia o general sedation) were used the application of cutaneous 
pads for defibrillation, transvenous temporary pacing, invasive arterial 
blood pressure and pulse oximetry monitoring. In our Hospital was also 
possible worked with the availability of cardiothoracic surgery stand-by. 
The procedures can been supported by intracardiac echography 
(ICE), performed using catheters equipped with an echo-transducer at the 
tip, introduced through the femoral vein. This is a recent technological 
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improvement very useful to monitoring the procedure, to determinate the 
real relationship between leads and anatomical structure, to detect the 
presence of vegetations and their outcome during dilation, finally to monitor 
the possible occurrence of early complications14. However, it result 
expensive and needed a dedicated operator, than we used ICE only in 
selected cases (such as difficult, old, intravascular or multiple leads and 
suspicion of vegetations). 
The Standard mechanical dilation technique was performed using the 
extraction system provided by Cook Vascular Inc. (Leechburg, PA, USA), 
equipped by polypropylene sheaths in different size (from 7 to 14 F) with 
the possibility of telescopic combination too, locking stylets and other  
specific tools (such as Transvenous workstation, tip deflecting wire, basket 
and loop retriever). The technique consist of a combination of different 
forces: traction by the stylet, rotation alternatively clockwise and counter-
clockwise by the inner dilating sheaths and countertraction at the tip of the 
lead by the outer telescopic one. The result could be the mechanical 
dissection of the adherences around the body lead, the detachment of the 
tip lead from the cardiac wall and the total removal from the venous tree. 
In case of exposed lead, i.e. when the proximal end is out of the 
venous entry site and accessible from the pace-maker pocket, we always 
used a superior approach as first choice. After the lead preparation (cutted 
and freed out of its venous entry site, than inserted the stylet and secured 
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by suture material), we performed the mechanical dilation in order to 
dissect the binding sites, following the course of the body lead until the tip. 
(Fig. 1) 
In case of free-floating leads, according to the global experience, we 
used as first choice an inferior approach, performed by the Transfemoral 
workstation (an extra-long sheath, 16 F, and other dedicated intravascular 
tools).(Fig. 2). When the lead tip result free, inside the venous system, 
through femoral vein can be used a Lasso loop-retriver to catch the tip and 
than pulled it back into the workstation, in order to remove the lead, also in 
case of adherences dilatation necessity (performed by use of the 
workstation sheath itself). When the lead present proximal end totally 
intravascular, not accessible from the pace-maker pocket and anchored tip 
in the heart, as the standard inferior approach described in leterature, we 
tried with Transfemoral workstation too15. In this case a deflecting wire is 
introduced trough the femoral vein in order to grasped the body lead and 
pulled the free proximal end in an inferior position, then trying to catched 
and dilated the lead from the low. 
According on our study design, only in case of standard technique 
failure and only in the randomised Group-B patients, we performed the 
Internal Transjugular Approach (ITA). (Fig. 3). In order to performed ITA, 
the right internal jugular vein was percutaneously cannulated using an 11 F 
introducer (Avanti, Cordis Corp., Miami, USA). After remove stylet and 
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suture from the lead (obviously only in case of exposed leads, no in 
intravascular ones), by a control tip deflecting wire (Cook Vascular Inc., 
Leechburg, PA, USA) introduced through the right femoral vein, the body 
lead was catched and pulled below, in order to slipping the proximal end at 
right atrium or superior vena cava level, making it free-floating. Then, 
through a Lasso loop-retriver (Osypka GmbH, Grentzig-Whylen, Germany) 
advanced into the jugular vein, the free-floating proximal end of the lead 
was captured and exteriorized in laterolcervical region. Now, a 
percutaneous procedure for exposed leads can been peformed, using 
dilating sheaths. (Fig. 4) 
According on the NASPE Guidelines, all the procedure results were 
defined based on the Radiological outcome (for one single lead) as:  
- complete success (removal of the whole lead),  
- partial success (removal of the lead except a fragment of less than 
4 centimeters from the tip),  
- failure (a significant fragment is left, or stop the procedure because 
of a major complication). 
Complications were classified as major or minor ones, according on 
the guidelines too. The major complications are tamponade, hemothorax, 
pulmonary embolism, led migration and death 
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RESULTS 
 
Between October 2005 and July 2007, we evaluated 112 consecutive 
patients (81 males, mean age 66.2 years) admitted at our E.P Laboratory 
for submission to transvenous lead extraction procedures (201 leads 
considered for removal, mean implant time 66 months). (Table 1). 
The patients were previously randomized with a simple order, into 
two Groups:  A) Standard Group,  
B) Internal Transjugular Approach (ITA) Group. 
The Standard group was formed by 56 patiens, of which 42 males 
(mean age 68 years); the procedure was performed for 98 leads (mean 
lead number for patient 2.15), with mean implant time 73 months. Pacing 
leads were 79 and implantable cardiac defibrillating 19; 32 were atrial, 58 
ventricular and 8 coronary sinus; only 4 were free-floating leads with 
proximal end intravascular, of which 1 atrial and 3 ventriculars. 
The ITA group was formed by 56 patiens too, of which 39 males 
(mean age 65 years); the procedure was performed for 103 leads (mean 
lead number for patient 2.2), with mean implant time 63 months. Pacing 
leads were 89 and implantable cardiac defibrillating 14; 37 were atrial, 56 
ventricular and 10 coronary sinus leads; only 6 were free-floating leads with 
proximal end intravascular, of which 4 atrial and 2 ventriculars (Table 2).  
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As demonstrated by the T-student statistical analysis, the two group 
didn’t have significant differences in theirs characteristics. 
According to the guidelines classification, in our population the 
indications to removal in A-Standard Group patients were: II-a) Localized 
pocket infection, erosion or chronic draining sinus that does not involve the 
transvenous portion of the lead (57.2%); I-a) Sepsis (including endocarditis) 
secondary to an infection of the pacing system (24.5%); II-g) Non-functional 
leads in a young patient (11.2%); II-d) A lead that, due to its design or its 
failure, may pose a threat to the patient (3.1%); I-b) Retained lead, lead 
fragment or extraction hardware (2%); II-b) Occult infection, i.e. no source 
can be found but pacing system is suspected (2%). Indications to removal 
in B-ITA Group patients were as following: II-a) 46.6%; I-a) 32%; II-g) 
14.6%; II-d) 5.8%; I-b) 1%; No occult infection (Table 3). 
Transvenous extraction was attempted in all the 98 leads belonged to 
the A-Group, with a total removal in 92 cases (success rate 93.9%), a 
partial removal in 1 case (1.02%) and 5 failure procedure (unsuccess rate 
5.1%). On the other hand, the transvenous extraction attempted in all the 
103 leads of B-Group was completely successful in 100 cases (success 
rate 97.1%), a partial success was obtained in 1 lead (1.9%) and 1 lead 
was not removed (unsuccess rate 1%). The comparative overall results are 
explicated in Table 4. 
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In the B-group the partial removal of two leads was achieved during 
the first step, before the cross-over to ITA; one lead was not removed 
because of a major complication (light cardiac tamponade) that stopped the 
procedure, before the cross-over to ITA, too. The jugular approach was 
performed as second step in 8 out of 103 leads, in which the standard 
technique of dilatation alone resulted ineffective (potential not success); all 
these 8 leads were totally removed (success rate of ITA 100%). The mean 
implantation time was 88 months; 4 of these were free-floating leads with 
intravascular proximal end (2 atrial and 2 ventricular), 4 were ventricular 
exposed leads (3 of which defibrillating leads); the leads location were 2 
atrial and 6 ventricular.  
The failure of standard technique in these 8 leads, that needed the 
cross-over to Internal Transjugular Approach, was due to different factors: 
impossibility to dilation free-floating leads through the inferior approach 
because of the lead course itself (4 pacing leads,of which 2 atrial and 2 
ventricular); lead damage, with impossibility of advancing the stylet (only 1 
ventricular pacing lead); calcified scar tissue that imprison the body lead 
strongly (2 defibrillating lead with adherences at Tricuspidalic or proximal 
coil’s level); difficulty to performed dilatation because of the rib-clavicular 
narrow or the Subclavian-Anonima corner (1 defibrillating lead). (Table 5). 
In our total population, major complication occurred in 2 cases 
(incidence rate 1.7%): one light pericardial effusion, treated with medical 
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therapy, and one cardiac tamponade with ventricular fibrillation and cardiac 
arrest, successfully treated with pericardiocentesis. Minor complications 
were: 2 lead implanted dislodgement, 18 cases of hypotension, 2 
substained Arrhythmias (not requiring electrical cardioversion), 1 
haematoma at the pacemaker pocket and 1 at the venous entry. However, 
no complications were directly related to the jugular approach. (Table 6) 
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DISCUSSION 
 
According to the global experience, our results confirm that 
transvenous lead extraction is actually a procedure effective and safe, able 
to resolve the device-related complications in patients with indications as 
codified in the current Guidelines. 
The success rate from the literature has a range from 96% and 90%, 
the failure from 0.6% and 3%, the major complications rate from 2.6% and 
1.3%. The most recent results of the US extraction Database were reported 
for 6420 leads in 4090 patients: 93% of the leads were completely 
extracted, 5% partially extracted and 2% not removed. Major complications 
occurred in 1,6% of patients, including a 0,2% mortality rate16. Another 
recent paper reported the US experience with laser sheaths; 2561 pacing 
and defibrillator leads were treated in 1684 patients at 89 sites in the United 
States. Of the leads, 90% were completely removed, 3% were partially 
removed, and the balance were failures. Major perioperative complications 
(tamponade, hemothorax, pulmonary embolism, lead migration and death) 
were observed in 1,9% of patients, with in-hospital death in 0,8%. Minor 
complications were observed in an additional 1,4% of patients.17  
Our results with standar mechanical technique are similar to the data 
described in literature and the major complication observed are also 
comparable. (Table 7) 
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The Aims of our study was to evalueted the effectiveness and safety 
of a particular approach, the Internal Transjugular one, that is really a 
modification of the standard mechanical dilatation and if this approach is 
able to enhance the standard technique itself about the success rate. 
This peculiar approach has been recently describe in literature18 19 in 
personal experiences and it could resolve some situations that affected the 
difficult procedures, for example the presence of free-floating or difficult 
exposed leads, representing a real improvement in transvenous lead 
extraction technique. 
As our study design show, we have compared two similar group; the 
first step was the same for all the patients, i.e. all the leads were 
approached with the standard technique using the more suitable approach , 
the superior or the inferior one, as describe in the most of the literature 
studies. Only in the B-Group, in case of standard approach failure, the 
procedure did not stopped and we performed a second step, trying to 
remove the lead through Internal Transjugular Approach. In order to 
guarantee the same treatment to all the patiens, we reserved ITA only as 
second possibility; the obvious consequence was that the cross-over to ITA 
was performed in more difficult cases, in which the normal procedure 
resulted not successed.  
In the B-Group, by using the standard tecnhique, we totally removed 
92 leads, partially removed 2 leads and 9 were the leads not removed; only 
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8 out of these 9 were submitted to the second step through Internal 
transjugular Approach, because in one case the procedure was stopped at 
the first step because of pericardial effusion and did not gone over. These 
leads were not removed with standard approaches because of theirs 
characteristics, that made difficult the procedure.  
According to the current opinions, the factors that strongly affected 
the succes rate of removal are the presence of free-floating leads, calcified 
scar tissue and the impossibillity to advance the stylet into the lead. By 
analysing the 8 not-removed leads in B-Group, treated with ITA as second 
step, we found that these were free-floating leads, damaged leads, leads 
imprisoned in strong adherences or not dilatable leads in the narrow rib-
clavicular space. All the 8 not removed leads with standard technique were 
totally removed after cross-over on ITA, without major complications.  
From a simple comparison between the A and B Group, we can 
observe a further significant increase from the yet elevated 93.9% success 
rate for the standard mechanical dilatation, to the more elevated 97.1% 
success rate considering the possibility of a cross-over to Internal 
Transjugular Approach in case of failure, without addictioned complications. 
As deduced from the literature experiences, the critical points 
conditioning the transvenous lead extraction procedures are the difficult 
sheath advancement (because of tight binding sites due to scar or calcified 
tissue, narrow corners in the lead course, tight space between the clavicle 
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and the first rib) or the impossibility to introduce the stylet (because of lead 
damage or intravascular location of the lead)20 21. 
In the critical case of exposed leads with tenacious adhesions sites 
the mechanical dilatation result often difficult because of the lead cours. In 
particular, the mechanical force of rotation and countertraction in addition to 
the traction one are not completely applied longitudinally over the body 
lead, when the vein entry site is the subclavian one; moreover, the dilation 
is more difficult in case of defibrillating leads, because of theirs major 
diameters and especially when the sub-clavicular space result very 
narrowed. When the lead is exposed in laterocervical site, during the 
Transjugular approach, it assume a new straight course from the jugular 
vein to the right atrium or ventricle; then, the mechanical dilatation result 
more easy, allowing the longitudinal axis of the lead, the traction and 
countertraction forces are more effective and the narrow subclavian-
clavicular space is by-passed. Besides, these conditions appeared to 
reduce the risk of complications, usually related to mechanical forces not 
longitudinally applied on the venous wall (risk of veins laceration) or to 
excessive countertraction on the lead tip (risk of myocardial invagination 
and rupture). 
Moreover, in case of free-floating lead, after holding the central body 
using Transfemoral workstation, the proximal end can be exposed in 
laterocervical space via the jugular approach and thus it can be submitted 
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to a standard procedure as in normal exposed leads, by-passing the 
specific difficulty of the intravascular leads. 
In our experience the possibility to adapt the technique to the specific 
situation may determine some advantages, improve the succes rate of the 
difficult procedures and reduce the complications risk. 
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CONCLUSIONS 
 
The technological improvement in the field of transvenous lead 
extraction is a needed consequence to resolve the increase of the 
indications to this procedure, also due to the recent increase of the number 
of implanted devices and theirs related complications. 
In case of malfunction or infection the solution may be the replacement 
of device, the repositioning or addiction of a new lead, finally the lead 
extraction before a new implant. The last one rapresent the best treatment, 
because it can completely resolve the trouble. Transvenous lead extraction is 
on the other hand a complex procedure, actually effective, but potentially 
burdened by severe complications and strongly dependent from the staff 
experience. Removal techniques are still considered to be in evolution in 
order to reach a gold standard, high success rate and low incidence of 
complications too. 
The Internal Transjugular Approach could represent, according on 
our experience, an useful modification to the standardized mechanical 
technique, able to improve the effectiveness of transvenous lead extraction 
expecially in case of difficult exposed or free-floating leads, increasing 
success rate and safety. 
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FIGURES 
Fig.1 Superior Approach  
 
Fig. 2. Inferior Approach 
 
Fig. 3 Transjugular Approach 
Superior Venous 
Inferior Venous Entry 
Transjugular 
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Fig. 4.Internal Transjugular Approach  
a) The lead is made free floating in the venous system by using the tip deflecting 
guide wire introduced via the femoral vein 
b) The proximal end of the lead is caught by the lassos and the lead is then 
exposed through the internal jugular vein 
c) Once the lead is exposed, a standard procedure is performed by using 
mechanical sheaths 
 
 
           a)                                       b)                                     c) 
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TABLES 
 
 
Table 1.Global Population 
Patients 112 
Age (years) 66 
Sex (male/female) 81/31 
No. Leads 201 
Mean implant time (months) 66  
  
 
 
Table 2. Randomized two Groups 
 A) Group B) Group 
No.Patients  56  56  
Mean age (years) 68 65 
Sex (M/F) (42/14) (39/17) 
No. Leads 98 103 
Mean implant time (months) 63 73 
Pacing/Defibrillating leads 79/19 89/14 
Location:   Atrial 
                 Ventricular 
                 Coronary sinus 
32 
58 
8 
37 
56 
10 
Esposed/Intravascular 94/4 97/6 
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Table 3. Indications to removal 
 A) Group B) Group 
II-a Localized pocket infection 57.2% 46.6% 
I-a Sepsis 24.5%  32% 
II-g Non-functional leads 11.2% 14.6% 
II-d Failure that may pose a 
threat to the pt. 
3.1% 5.8% 
I-b Retained lead 2% 1% 
II-b Occult infection 2% - 
 
 
Table 4. Results 
 A) Group B) Group  
Total removal 92 leads (93.9%) 100 leads (97.1%) 
Partial removal 1 lead (1.02%)- 2 lead (1.9%) 
Failure 5 leads (5.1%) 1 lead (1%) 
 
 
Table 5. Causes of standard technique failure in the sub-group of 8 
leads that were submitted on the second step with ITA in the B) Group. 
 
Free-floating leads 4 pacing leads 
Damage 1 pacing lead 
Strongly adherences  2 defib leads 
Rib-clavicular narrow 1 defib. lead 
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Table 6.Global complications.  
 
Major  - 1 pericardial effusion 
- 1 cardiac tamponade with VF and cardiac arrest 
Minor - 2 lead implanted dislodgement 
- 18 hypotension 
- 2 subtained arrhythmias non requiring el. Cardiovertion 
- 1 haematoma at the PM pocket 
- 1 haematoma at the venous entry 
 
 
Table 7. Comparison between our results and the most recent literature. 
 
 US Extraction 
Database 
US 
experience-
Laser 
Wilkoff NASPE 
2000 
Byrd PACE 
25,2002 Our experience 
Pts/leads 4090/6420 1684/2561 2104/3355 1684/2561 112/201 
Rate of 
removal (%) 
93% 90% 94% 90% 
93.9%(Standard)
97.1% (ITA) 
Major 
complications 
1.6% 1.9% 1.3% 1.9% 1.7% 
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